44 completed, 5 unknown, 3 recruiting, 2 terminated. 55 Phase 2, 7 Phase 1, 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 55 | Completed 44, Unknown 5, Recruiting 3, Terminated 2, Withdrawn 1 |
| Phase 1 | 7 | Completed 6, Recruiting 1 |
| Phase 3 | 3 | Completed 3 |
Follow Contraception: new trials by email Literature Review of Contraception trials Research Report on Contraception
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Long Term Evaluation of Scapular-inserted Contraceptive Implants Scapular-site insertion of etonogestrel contraceptive implant - Contraception | Phase 2 | Recruiting | Yale University | 62 | 2026-05-08 | 2026-10-07 |
| Investigating Ovulation Inhibition for Use as a Contraceptive MR-130A-01 contraceptive transdermal patch, containing norelgestromin (NGMN) - Contraception | Phase 2 | Recruiting | Mylan Pharmaceuticals Inc | 60 | 2025-12-22 | 2026-01-26 |
| Pharmacokinetics of Drospirenone Only Pills: A Pre- and Post-Bariatric Surgery Study Drospirenone - Contraception | Phase 1 / Phase 2 | Recruiting | Chulalongkorn University | 16 | 2024-04-18 | 2026-03-19 |
| Dose-finding Study of MR-130A-01 Contraceptive Transdermal Patch MR-130A-01 Transdermal patch - Contraception | Phase 2 | Completed | Mylan Pharmaceuticals Inc | 168 | 2023-12-22 | 2024-11-29 |
| Drospirenone-only Pill as Emergency Contraception Drospirenone-only pill - Contraception | Phase 2 | Unknown | University of Colorado, Denver | 35 | 2023-02-01 | 2023-01-09 |
| The PRICE Trial: Pain Reduction for Intrauterine Contraception Experiment 1% Lidocaine Paracervical Block, Normal Saline Paracervical Injection - Contraception | Phase 2 | Completed | Mount Sinai Hospital, Canada | 246 | 2022-06-30 | 2025-01-27 |
| Study of the Safety and Efficacy of Ulipristal Acetate (UPA) Used Daily as a Contraceptive Ulipristal acetate - Contraception, Healthy Female | Phase 2 | Withdrawn | Premier Research | 2020-12-01 | 2025-11-20 | |
| Pharmacologic Strategies for the Etonogestrel Implant in HIV-Infected Women etonogestrel implant - HIV/AIDS, Contraception | Phase 2 | Completed | Catherine Anne Chappell | 72 | 2019-02-19 | 2024-09-05 |
| Tenofovir/Levonorgestrel Intravaginal Ring and Tenofovir Intravaginal Ring TFV/LNG IVR, TFV IVR, Placebo IVR - HIV, Contraception | Phase 2 | Unknown | CONRAD | 50 | 2018-12-12 | 2020-01-14 |
| Darunavir and Rilpivirine Interactions With Etonogestrel Contraceptive Implant Etonogestrel 68Mg Implant, rilpivirine, darunavir - HIV, Contraception | Phase 2 | Unknown | Makerere University | 60 | 2018-09-25 | 2019-03-28 |
| Darunavir and Rilpivirine Interactions With Levonorgestrel Implant Levonorgestrel two rod sub-dermal implant, Rilpivirine, Darunavir+Ritonavir - HIV-1-infection, Contraception | Phase 2 | Unknown | Makerere University | 60 | 2018-08-07 | 2019-03-28 |
| Effect of Norgestrel 75 mcg on Cervical Mucus and Ovarian Activity During Perfect Use, After One Delayed Intake and After a Missed Pill Norgestrel 0.075 mg - Contraception | Phase 2 | Completed | HRA Pharma | 52 | 2018-07-24 | 2021-06-03 |
| A Study to Compare 3 Doses of a Hormonal Intra-uterine Device Containing Levonorgestrel and Indomethacin With a Hormonal Intra-uterine Device Containing Only Levonorgestrel to Assess the Effect and Safety of the Combined Components BAY98-7443, Levonogestrel (Skyla, BAY86-5028) - Contraception | Phase 2 | Completed | Bayer | 177 | 2018-06-22 | 2019-08-12 |
| Pharmacologic Strategies to Use the Levonorgestrel Implant in HIV-infected Women Levonorgestrel, Efavirenz - HIV, Contraception | Phase 2 | Completed | University of Nebraska | 28 | 2017-04-06 | 2024-10-03 |
| Evaluation of the Efficacy and Safety of LevoCept LevoCept - Contraception | Phase 2 | Completed | Sebela Women's Health Inc. | 279 | 2016-11-01 | 2026-04-23 |
| "E4/DRSP Endocrine Function, Metabolic Control and Hemostasis Study" 15 mg E4/3 mg DRSP, 30 mcg EE/150 mcg LNG, 20 mcg EE/3 mg DRSP - Contraception, Liver Metabolism | Phase 1 / Phase 2 | Completed | Estetra | 101 | 2016-09-01 | 2018-02-05 |
| Evaluation of a Novel and Simplified Technique for Intrauterine Contraceptive Devices Insertion: a Prospective Cohort Study IUD, Uterine sounding, Transvaginal ultrasound - Contraception | Phase 2 | Completed | Assiut University | 90 | 2016-01-01 | 2016-11-25 |
| The Effect of Ibuprofen on Intrauterine Contraceptive Device Associated Uterine Bleeding Ibuprofen - Contraception | Phase 2 | Completed | Assiut University | 128 | 2015-10-01 | 2017-03-21 |
| Russia/Ukraine Suppression of Ovarian Activity Study Gestodene/EE Patch (BAY86-5016) - Contraception | Phase 2 | Completed | Bayer | 91 | 2015-09-18 | 2017-08-07 |
| To Investigate the Pharmacological Effects, Drug Blood Levels and Safety of an Intrauterine System Releasing the Study Drug BAY1007626 in Comparison to Mirena and Jaydess in Healthy Young Women Treated for 90 Days to Determine the Drug Dose for Further Development BAY1007626, Jaydess, Mirena - Contraception | Phase 2 | Terminated | Bayer | 174 | 2015-06-22 | 2019-06-04 |
Showing 20 of 55. Sign in to see all of them.
Acquired Immunodeficiency Syndrome (2) · Genital Diseases, Female (1) · HIV Infections (1) · Hypogonadism (1) · Inflammation (1) · Insulin Resistance (1) · Obesity (1) · Thrombosis (1) · Tobacco Use Disorder (1) · Uterine Hemorrhage (1)
Genital Diseases (4) · Urogenital Diseases (4) · Pathological Conditions, Signs and Symptoms (3) · Blood-Borne Infections (2) · Communicable Diseases (2) · Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Immune System Diseases (2) · Immunologic Deficiency Syndromes (2) · Infections (2) · Lentivirus Infections (2) · Nutritional and Metabolic Diseases (2) · Pathologic Processes (2) · RNA Virus Infections (2) · Retroviridae Infections (2)
Ethinyl Estradiol (7) · Levonorgestrel (7) · etonogestrel (4) · Estradiol (3) · Gestodene (3) · Medroxyprogesterone Acetate (3) · Testosterone (3) · drospirenone (3) · ulipristal (3) · Dutasteride (2) · Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination (2) · Estetrol (2) · N,N-dimethyl-4-anisidine (2) · Rilpivirine (2) · acyline (2)
Bayer (12) · University of Washington (5) · CONRAD (3) · HRA Pharma (3) · Organon and Co (3) · Assiut University (2) · Estetra (2) · Makerere University (2) · Mylan Pharmaceuticals Inc (2) · Population Council (2) · Premier Research (2) · Sebela Women's Health Inc. (2) · University of Colorado, Denver (2) · University of Nebraska (2) · Catherine Anne Chappell (1)
United States (21) · Germany (12) · Uganda (5) · Netherlands (4) · United Kingdom (3) · Chile (2) · Dominican Republic (2) · Egypt (2) · Finland (2) · Belgium (1) · Canada (1) · France (1) · Hungary (1) · Kenya (1) · Norway (1)
Mohammed Lamorde, PhD (2) · Sandeep Jagtap (2) · William J Bremner, MD, PhD (2) · Aaron Lazorwitz, MD (1) · Alfred Poindexter, MD (1) · Alison Edelman, MD (1) · Anita L Nelson, MD (1) · Catherine A Chappell, MD MSc (1) · Christine K Mauck, MD (1) · Christine Klipping (1) · Dan Apter, M.D. (1) · David Archer, MD (1) · David F Archer, MD (1) · David Turok, MD (1)
PMID 17494097, PMID 10560680, PMID 11245554, PMID 11433905, PMID 12841897, PMID 16940442, PMID 17303493, PMID 17579200, PMID 18046048, PMID 18077826, PMID 18413423, PMID 19461456, PMID 20634186, PMID 21721593, PMID 22222193, PMID 23265980, PMID 24043457, PMID 2449395, PMID 24726226, PMID 25393993, PMID 25751199, PMID 25880636, PMID 26181091, PMID 26232513, PMID 26646680, PMID 26965870, PMID 27467196, PMID 28433989, PMID 29634911, PMID 30203681, PMID 30347490, PMID 31370907, PMID 31493139, PMID 31758920, PMID 32168217, PMID 32202076, PMID 32312141, PMID 33008401, PMID 33547015, PMID 33970869, PMID 3450848, PMID 35835755, PMID 36103980, PMID 36162740, PMID 36316023, PMID 36648744, PMID 37383290, PMID 37544572, PMID 38458408, PMID 7068318
U54HD042454 (3), 2008 (2), 2009 (2), K23HD045386 (2), 2004 (1), 2016 (1), 2018 (1), R01HD085887 (1), R21HD074462 (1), R56HD117869 (1)